We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
With an experimental spinal cord implant trial on hold for more than six months, Cambridge, Mass.-based InVivo Therapeutics has been rapidly burning through cash and may not have enough financing to continue operations for much longer.